Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

This study is testing whether an investigational injection called TQH2929 can quickly clear painful, pus-filled skin flare-ups in people with generalized pustular psoriasis. It will compare the injection to a placebo (dummy treatment) in 36 adults experiencing an acute flare. The…

This is an early safety study testing a new drug called TQB3002 in 150 patients with advanced cancers who have run out of standard treatment options. The main goals are to find the highest safe dose and check for side effects. This is the first time this drug is being tested in p…

This is the first time researchers are giving the experimental capsule TQB3122 to people. The main goal is to check how safe it is, what side effects occur, and how the body processes it in adults with advanced solid tumors that have stopped responding to standard treatments. The…

This is a first-in-human study to test the safety and find the right dose of an experimental oral drug called TQB3019 for adults with advanced cancer. The main goals are to see what side effects occur, how the drug moves through the body, and to check for any early signs that it …

This study is testing the safety and effectiveness of two oral drugs, TQ05105 and TQB3617, when taken together by adults with intermediate- or high-risk myelofibrosis. The main goals are to find the best dose and to see if the treatment can shrink enlarged spleens and reduce dise…

This study is testing an investigational inhaled powder called TQC3721 for people with moderate to severe COPD. The main goal is to see if it safely improves lung function and reduces symptoms compared to a placebo. About 195 participants will use the inhaler for four weeks while…

This study is testing a new drug called LM-108, given alongside an immunotherapy drug and two standard chemotherapy drugs, for people with advanced pancreatic cancer that cannot be removed by surgery. The main goals are to see if this combination is safe and if it can help contro…

This study is testing a new drug called Rovadicitinib for people with moderate-to-severe chronic graft-versus-host disease (cGVHD) who have already tried at least two other treatments. It aims to see if Rovadicitinib is better than other standard treatments at reducing symptoms a…

This study is testing whether a new capsule called AL2846 can help control advanced thyroid cancer that has stopped responding to standard treatments. It will compare AL2846 against a placebo in 144 adults whose cancer has progressed despite previous therapy. The main goal is to …

This study is testing a new drug, TQB2825, combined with standard chemotherapy for people with diffuse large B-cell lymphoma, a fast-growing blood cancer. It aims to see if the combination is safe and more effective at controlling the disease, especially for patients who are newl…

This study is testing the long-term safety and effectiveness of an investigational injection called TQH2722 for people with severe chronic sinusitis, with or without nasal polyps. It will involve about 120 adults who previously took part in an earlier study of the same drug. Rese…

This is the first human study testing a new diabetes medication called TQF3250 capsules. Researchers will give the drug to 66 healthy adults to check its safety, how the body processes it, and what side effects might occur. The goal is to see if this new type of medication could …

This clinical trial is testing an experimental drug called TQB6411 injection for people with advanced esophageal cancer that has returned or spread. The study aims to find the safest dose and see if the drug can help control the cancer in patients whose previous treatments with i…